Clinical Trial Update: Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) [Phase 2]

View source ↗

Summary

The Phase 2 study of EYP-1901 in wet age-related macular degeneration has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• EYP-1901

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Wet Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2025-10-02